{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:37:31Z","timestamp":1790372251423,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00346770"],"award-info":[{"award-number":["RS-2024-00346770"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>O<\/jats:italic>\n                    -GlcNAcylation, a nutrient-sensitive post-translational modification, has emerged as a key regulator of immune and inflammatory processes. However, its role in neuroinflammation and neurodegenerative disease progression remains poorly defined. In this study, we explored how reduced\n                    <jats:italic>O<\/jats:italic>\n                    -GlcNAcylation contributes to neuroinflammatory signaling in Parkinson\u2019s disease (PD), a disorder increasingly recognized to involve dysregulated immune\u2013metabolic interactions. Analysis of postmortem PD substantia nigra (SN) revealed a marked reduction in global\n                    <jats:italic>O<\/jats:italic>\n                    -GlcNAcylation levels, concomitant with enhanced neuroinflammatory signatures and a predominance of pro-inflammatory microglial activation states. In a lipopolysaccharide (LPS)-induced PD mouse model, pharmacological elevation of\n                    <jats:italic>O<\/jats:italic>\n                    -GlcNAcylation through glucosamine (GlcN) or the Thiamet-G significantly ameliorated motor deficits, preserved tyrosine hydroxylase (TH)-positive dopaminergic neurons, and attenuated neuroinflammatory responses, including glial activation and inflammasome assembly. In primary microglial cultures, enhanced\n                    <jats:italic>O<\/jats:italic>\n                    -GlcNAcylation suppressed LPS-induced pro-inflammatory gene expression while promoting anti-inflammatory and homeostatic phenotypes. Mechanistically, increased\n                    <jats:italic>O<\/jats:italic>\n                    -GlcNAcylation dampened NF-\u03baB signaling activity and reduced the production of pro-inflammatory cytokines, thereby reprogramming microglial functional states. Collectively, these findings identify\n                    <jats:italic>O<\/jats:italic>\n                    -GlcNAcylation as a critical modulator of microglial-mediated neuroinflammation and highlight its therapeutic potential for inflammation-associated neurodegenerative disorders such as PD.\n                  <\/jats:p>","DOI":"10.1038\/s41531-026-01319-6","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T10:06:31Z","timestamp":1774692391000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["O-GlcNAcylation regulates microglial neuroinflammation in Parkinson\u2019s disease"],"prefix":"10.1038","volume":"12","author":[{"given":"Dong Yeol","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanhaeng","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inn-Oc","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"key":"1319_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe, W. et al. Parkinson disease. Nat. Rev. Dis. Prim. 3, 17013 (2017).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"1319_CR2","doi-asserted-by":"publisher","first-page":"238","DOI":"10.2174\/1381612822666151112151653","volume":"22","author":"A Sarrafchi","year":"2016","unstructured":"Sarrafchi, A., Bahmani, M., Shirzad, H. & Rafieian-Kopaei, M. Oxidative stress and Parkinson\u2019s disease: New hopes in treatment with herbal antioxidants. Curr. Pharm. Des. 22, 238\u2013246 (2016).","journal-title":"Curr. Pharm. Des."},{"key":"1319_CR3","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.nbd.2017.04.004","volume":"109","author":"EM Rocha","year":"2018","unstructured":"Rocha, E. M., De Miranda, B. & Sanders, L. H. Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson\u2019s disease. Neurobiol. Dis. 109, 249\u2013257 (2018).","journal-title":"Neurobiol. Dis."},{"key":"1319_CR4","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/4784268","volume":"2018","author":"G Gelders","year":"2018","unstructured":"Gelders, G., Baekelandt, V. & Van der Perren, A. Linking Neuroinflammation and Neurodegeneration in Parkinson\u2019s Disease. J. Immunol. Res. 2018, 4784268 (2018).","journal-title":"J. Immunol. Res."},{"key":"1319_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2023.578180","volume":"383","author":"K Biswas","year":"2023","unstructured":"Biswas, K. Microglia mediated neuroinflammation in neurodegenerative diseases: A review on the cell signaling pathways involved in microglial activation. J. Neuroimmunol. 383, 578180 (2023).","journal-title":"J. Neuroimmunol."},{"key":"1319_CR6","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/s41593-018-0242-x","volume":"21","author":"S Hickman","year":"2018","unstructured":"Hickman, S., Izzy, S., Sen, P., Morsett, L. & El Khoury, J. Microglia in neurodegeneration. Nat. Neurosci. 21, 1359\u20131369 (2018).","journal-title":"Nat. Neurosci."},{"key":"1319_CR7","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/nm.4397","volume":"23","author":"MW Salter","year":"2017","unstructured":"Salter, M. W. & Stevens, B. Microglia emerge as central players in brain disease. Nat. Med. 23, 1018\u20131027 (2017).","journal-title":"Nat. Med."},{"key":"1319_CR8","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/bph.13139","volume":"173","author":"R Orihuela","year":"2016","unstructured":"Orihuela, R., McPherson, C. A. & Harry, G. J. Microglial M1\/M2 polarization and metabolic states. Br. J. Pharm. 173, 649\u2013665 (2016).","journal-title":"Br. J. Pharm."},{"key":"1319_CR9","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","volume":"35","author":"M Colonna","year":"2017","unstructured":"Colonna, M. & Butovsky, O. Microglia Function in the Central Nervous System During Health and Neurodegeneration. Annu. Rev. Immunol. 35, 441\u2013468 (2017).","journal-title":"Annu. Rev. Immunol."},{"key":"1319_CR10","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s12035-014-9070-5","volume":"53","author":"Y Tang","year":"2016","unstructured":"Tang, Y. & Le, W. Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases. Mol. Neurobiol. 53, 1181\u20131194 (2016).","journal-title":"Mol. Neurobiol."},{"key":"1319_CR11","doi-asserted-by":"publisher","unstructured":"Pajares, M., A, I. R., Manda, G., Bosca, L. & Cuadrado, A. Inflammation in Parkinson\u2019s Disease: Mechanisms and Therapeutic Implications. Cells 9, https:\/\/doi.org\/10.3390\/cells9071687 (2020).","DOI":"10.3390\/cells9071687"},{"key":"1319_CR12","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.neuint.2015.06.004","volume":"87","author":"N Sharma","year":"2015","unstructured":"Sharma, N. & Nehru, B. Characterization of the lipopolysaccharide induced model of Parkinson\u2019s disease: Role of oxidative stress and neuroinflammation. Neurochem Int 87, 92\u2013105 (2015).","journal-title":"Neurochem Int"},{"key":"1319_CR13","volume":"2011","author":"M Liu","year":"2011","unstructured":"Liu, M. & Bing, G. Lipopolysaccharide animal models for Parkinson\u2019s disease. Parkinsons Dis. 2011, 327089 (2011).","journal-title":"Parkinsons Dis."},{"key":"1319_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-014-0230-3","volume":"12","author":"SP Fu","year":"2015","unstructured":"Fu, S. P. et al. Anti-inflammatory effects of BHBA in both in vivo and in vitro Parkinson\u2019s disease models are mediated by GPR109A-dependent mechanisms. J. Neuroinflamm. 12, 9 (2015).","journal-title":"J. Neuroinflamm."},{"key":"1319_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2020.100060","volume":"4","author":"I Deng","year":"2020","unstructured":"Deng, I., Corrigan, F., Zhai, G., Zhou, X. F. & Bobrovskaya, L. Lipopolysaccharide animal models of Parkinson\u2019s disease: Recent progress and relevance to clinical disease. Brain Behav. Immun. Health 4, 100060 (2020).","journal-title":"Brain Behav. Immun. Health"},{"key":"1319_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02496-w","volume":"19","author":"A Heidari","year":"2022","unstructured":"Heidari, A., Yazdanpanah, N. & Rezaei, N. The role of Toll-like receptors and neuroinflammation in Parkinson\u2019s disease. J. Neuroinflamm. 19, 135 (2022).","journal-title":"J. Neuroinflamm."},{"key":"1319_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-024-03043-5","volume":"21","author":"C Yildirim-Balatan","year":"2024","unstructured":"Yildirim-Balatan, C. et al. Parkinson\u2019s disease-derived alpha-synuclein assemblies combined with chronic-type inflammatory cues promote a neurotoxic microglial phenotype. J. Neuroinflamm. 21, 54 (2024).","journal-title":"J. Neuroinflamm."},{"key":"1319_CR18","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.nbd.2017.08.009","volume":"108","author":"EE Beier","year":"2017","unstructured":"Beier, E. E. et al. Alternative microglial activation is associated with cessation of progressive dopamine neuron loss in mice systemically administered lipopolysaccharide. Neurobiol. Dis. 108, 115\u2013127 (2017).","journal-title":"Neurobiol. Dis."},{"key":"1319_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","volume":"4","author":"Q Wang","year":"2015","unstructured":"Wang, Q., Liu, Y. & Zhou, J. Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target. Transl. Neurodegener. 4, 19 (2015).","journal-title":"Transl. Neurodegener."},{"key":"1319_CR20","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.cnr.2006.09.006","volume":"6","author":"RL Mosley","year":"2006","unstructured":"Mosley, R. L. et al. Neuroinflammation, oxidative stress and the pathogenesis of Parkinson\u2019s disease. Clin. Neurosci. Res 6, 261\u2013281 (2006).","journal-title":"Clin. Neurosci. Res"},{"key":"1319_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.102032","volume":"90","author":"H Yu","year":"2023","unstructured":"Yu, H. et al. Metabolic reprogramming and polarization of microglia in Parkinson\u2019s disease: Role of inflammasome and iron. Ageing Res Rev. 90, 102032 (2023).","journal-title":"Ageing Res Rev."},{"key":"1319_CR22","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s10565-024-09900-6","volume":"40","author":"Y Zhao","year":"2024","unstructured":"Zhao, Y. et al. TRAF6 promotes spinal microglial M1 polarization to aggravate neuropathic pain by activating the c-JUN\/NF-kB signaling pathway. Cell Biol. Toxicol. 40, 54 (2024).","journal-title":"Cell Biol. Toxicol."},{"key":"1319_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1398-3","volume":"16","author":"Q Liu","year":"2019","unstructured":"Liu, Q. et al. Cathepsin C promotes microglia M1 polarization and aggravates neuroinflammation via activation of Ca(2+)-dependent PKC\/p38MAPK\/NF-kappaB pathway. J. Neuroinflamm. 16, 10 (2019).","journal-title":"J. Neuroinflamm."},{"key":"1319_CR24","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.bbalip.2006.04.007","volume":"1761","author":"NE Zachara","year":"2006","unstructured":"Zachara, N. E. & Hart, G. W. Cell signaling, the essential role of O-GlcNAc!. Biochim Biophys. Acta 1761, 599\u2013617 (2006).","journal-title":"Biochim Biophys. Acta"},{"key":"1319_CR25","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.cmet.2014.07.014","volume":"20","author":"S Hardiville","year":"2014","unstructured":"Hardiville, S. & Hart, G. W. Nutrient regulation of signaling, transcription, and cell physiology by O-GlcNAcylation. Cell Metab. 20, 208\u2013213 (2014).","journal-title":"Cell Metab."},{"key":"1319_CR26","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nrm.2017.22","volume":"18","author":"X Yang","year":"2017","unstructured":"Yang, X. & Qian, K. Protein O-GlcNAcylation: emerging mechanisms and functions. Nat. Rev. Mol. Cell Biol. 18, 452\u2013465 (2017).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1319_CR27","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s12192-020-01177-y","volume":"26","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. O-GlcNAcylation: the \u201cstress and nutrition receptor\u201d in cell stress response. Cell Stress Chaperones 26, 297\u2013309 (2021).","journal-title":"Cell Stress Chaperones"},{"key":"1319_CR28","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1074\/jbc.AW119.003226","volume":"294","author":"GW Hart","year":"2019","unstructured":"Hart, G. W. Nutrient regulation of signaling and transcription. J. Biol. Chem. 294, 2211\u20132231 (2019).","journal-title":"J. Biol. Chem."},{"key":"1319_CR29","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s00011-015-0877-y","volume":"64","author":"D Zhang","year":"2015","unstructured":"Zhang, D. et al. OGT-mediated O-GlcNAcylation promotes NF-kappaB activation and inflammation in acute pancreatitis. Inflamm. Res. 64, 943\u2013952 (2015).","journal-title":"Inflamm. Res."},{"key":"1319_CR30","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.immuni.2019.03.008","volume":"50","author":"X Li","year":"2019","unstructured":"Li, X. et al. O-GlcNAc Transferase Suppresses Inflammation and Necroptosis by Targeting Receptor-Interacting Serine\/Threonine-Protein Kinase 3. Immunity 50, 1115 (2019).","journal-title":"Immunity"},{"key":"1319_CR31","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1002\/glia.21058","volume":"58","author":"SY Hwang","year":"2010","unstructured":"Hwang, S. Y. et al. Glucosamine exerts a neuroprotective effect via suppression of inflammation in rat brain ischemia\/reperfusion injury. Glia 58, 1881\u20131892 (2010).","journal-title":"Glia"},{"key":"1319_CR32","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1074\/jbc.RA118.004638","volume":"294","author":"JS Hwang","year":"2019","unstructured":"Hwang, J. S. et al. Glucosamine improves survival in a mouse model of sepsis and attenuates sepsis-induced lung injury and inflammation. J. Biol. Chem. 294, 608\u2013622 (2019).","journal-title":"J. Biol. Chem."},{"key":"1319_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06670-1","volume":"15","author":"DY Kim","year":"2024","unstructured":"Kim, D. Y., Kim, S. M., Cho, E. J., Kwak, H. B. & Han, I. O. Protective effect of increased O-GlcNAc cycling against 6-OHDA-induced Parkinson\u2019s disease pathology. Cell Death Dis. 15, 287 (2024).","journal-title":"Cell Death Dis."},{"key":"1319_CR34","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/glia.22762","volume":"63","author":"T Taetzsch","year":"2015","unstructured":"Taetzsch, T. et al. Redox regulation of NF-kappaB p50 and M1 polarization in microglia. Glia 63, 423\u2013440 (2015).","journal-title":"Glia"},{"key":"1319_CR35","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41401-020-0358-x","volume":"41","author":"JQ Liu","year":"2020","unstructured":"Liu, J. Q. et al. Rg1 improves LPS-induced Parkinsonian symptoms in mice via inhibition of NF-kappaB signaling and modulation of M1\/M2 polarization. Acta Pharm. Sin. 41, 523\u2013534 (2020).","journal-title":"Acta Pharm. Sin."},{"key":"1319_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-025-03462-y","volume":"22","author":"F Lind-Holm Mogensen","year":"2025","unstructured":"Lind-Holm Mogensen, F., Seibler, P., Grunewald, A. & Michelucci, A. Microglial dynamics and neuroinflammation in prodromal and early Parkinson\u2019s disease. J. Neuroinflamm. 22, 136 (2025).","journal-title":"J. Neuroinflamm."},{"key":"1319_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-2-14","volume":"2","author":"E Croisier","year":"2005","unstructured":"Croisier, E., Moran, L. B., Dexter, D. T., Pearce, R. K. & Graeber, M. B. Microglial inflammation in the Parkinsonian substantia nigra: relationship to alpha-synuclein deposition. J. Neuroinflamm. 2, 14 (2005).","journal-title":"J. Neuroinflamm."},{"key":"1319_CR38","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40035-025-00467-8","volume":"14","author":"L Chen","year":"2025","unstructured":"Chen, L., Wang, C., Qin, L. & Zhang, H. Parkinson\u2019s disease and glucose metabolism impairment. Transl. Neurodegener. 14, 10 (2025).","journal-title":"Transl. Neurodegener."},{"key":"1319_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2023.110672","volume":"199","author":"C Dai","year":"2023","unstructured":"Dai, C. et al. Glucose metabolism impairment in Parkinson\u2019s disease. Brain Res Bull. 199, 110672 (2023).","journal-title":"Brain Res Bull."},{"key":"1319_CR40","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1016\/S0002-9440(10)64487-2","volume":"161","author":"JH Zhu","year":"2002","unstructured":"Zhu, J. H., Kulich, S. M., Oury, T. D. & Chu, C. T. Cytoplasmic aggregates of phosphorylated extracellular signal-regulated protein kinases in Lewy body diseases. Am. J. Pathol. 161, 2087\u20132098 (2002).","journal-title":"Am. J. Pathol."},{"key":"1319_CR41","doi-asserted-by":"publisher","unstructured":"Gordon, R. et al. Inflammasome inhibition prevents alpha-synuclein pathology and dopaminergic neurodegeneration in mice. Sci. Transl. Med. 10, https:\/\/doi.org\/10.1126\/scitranslmed.aah4066 (2018).","DOI":"10.1126\/scitranslmed.aah4066"},{"key":"1319_CR42","doi-asserted-by":"publisher","first-page":"7531","DOI":"10.1073\/pnas.94.14.7531","volume":"94","author":"S Hunot","year":"1997","unstructured":"Hunot, S. et al. Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with Parkinson disease. Proc. Natl. Acad. Sci. USA 94, 7531\u20137536 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1319_CR43","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13024-025-00904-2","volume":"20","author":"Y Miao","year":"2025","unstructured":"Miao, Y. et al. Modulation of O-GlcNAc cycling influences alpha-synuclein amplification, degradation, and associated neuroinflammatory pathology. Mol. Neurodegener. 20, 113 (2025).","journal-title":"Mol. Neurodegener."},{"key":"1319_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2025.106014","volume":"188","author":"S Zhu","year":"2025","unstructured":"Zhu, S., Wang, N., Chen, S., Zou, J. & Tan, S. Thiamet-G ameliorates Parkinson\u2019s disease-associated cognitive impairment via increasing O-GlcNAcylation of STING in the microglia. Neurochem. Int. 188, 106014 (2025).","journal-title":"Neurochem. Int."},{"key":"1319_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02187-y","volume":"18","author":"J Cheng","year":"2021","unstructured":"Cheng, J. et al. Early glycolytic reprogramming controls microglial inflammatory activation. J. Neuroinflamm. 18, 129 (2021).","journal-title":"J. Neuroinflamm."},{"key":"1319_CR46","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1101\/gad.1985910","volume":"24","author":"KE Wellen","year":"2010","unstructured":"Wellen, K. E. et al. The hexosamine biosynthetic pathway couples growth factor-induced glutamine uptake to glucose metabolism. Genes Dev. 24, 2784\u20132799 (2010).","journal-title":"Genes Dev."},{"key":"1319_CR47","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/cr.2015.68","volume":"25","author":"B Kelly","year":"2015","unstructured":"Kelly, B. & O\u2019Neill, L. A. Metabolic reprogramming in macrophages and dendritic cells in innate immunity. Cell Res. 25, 771\u2013784 (2015).","journal-title":"Cell Res."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01319-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01319-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01319-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:03:13Z","timestamp":1779408193000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01319-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1319"],"URL":"https:\/\/doi.org\/10.1038\/s41531-026-01319-6","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]},"assertion":[{"value":"3 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"121"}}